Updated

Amazon to buy PillPack in potentially disruptive drug retail push

Jun 28, 2018

By Ankur Banerjee and Bill Berkrot (Reuters) – Amazon.com Inc said on Thursday it would buy...

U.S. charges hundreds in healthcare fraud, opioid crackdown

Jun 28, 2018

By Nate Raymond (Reuters) – The U.S. Justice Department on Thursday announced charges...

Congo completes surveillance of Ebola contacts, no new cases

Jun 28, 2018

GOMA, Democratic Republic of Congo (Reuters) – Democratic Republic of Congo moved closer to declaring its Ebola outbreak over when the health ministry said it had completed surveillance of the last people who came into...

U.S. jury orders DaVita to pay $383.5 million in wrongful death lawsuits

Jun 28, 2018

By Nate Raymond (Reuters) – A federal jury in Colorado has awarded $383.5 million to the...

AI ambulances and robot doctors: China seeks digital salve to ease hospital strain

Jun 28, 2018

By Adam Jourdan HANGZHOU, China/SHANGHAI (Reuters) – In the eastern Chinese city of...

U.S. Supreme Court to hear Merck appeal over Fosamax suits

Jun 28, 2018

By Andrew Chung WASHINGTON (Reuters) – The U.S. Supreme Court on Thursday agreed to hear...

WTO to rule on landmark tobacco case later on Thursday

Jun 28, 2018

By Tom Miles GENEVA (Reuters) – Ultra-plain packaging for tobacco products might become the...

Feeling poorly? The app will see you now

Jun 28, 2018

By Paul Sandle LONDON (Reuters) – London-based Babylon Health says its artificial...

Array BioPharma gets FDA nod for melanoma combo treatment

Jun 27, 2018

By Anuron Kumar Mitra and Tamara Mathias (Reuters) – The U.S. Food and Drug Administration...

Summit plunges 80 percent after muscle-wasting disorder drug fails

Jun 27, 2018

(Reuters) – Britain’s Summit Therapeutics Plc said on Wednesday that it would stop developing its Duchenne muscular dystrophy (DMD) drug after it failed a mid-stage study, wiping out nearly 80 percent of its market...

GBT’s drug meets trial goal, investors skeptical of speedy approval

Jun 27, 2018

By Manas Mishra and Tamara Mathias (Reuters) – Global Blood Therapeutics Inc’s sickle cell disease treatment met the main goal of a late-stage trial, but scepticism over whether the drug would get an accelerated...

Aquinox to stop development of lead drug; shares plunge

Jun 27, 2018

(Reuters) – Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its main drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, pushing its shares down as much...

AstraZeneca, Merck eye $1 billion boost from cancer drug success

Jun 27, 2018

By Ben Hirschler LONDON (Reuters) – AstraZeneca’s <AZN.L> oncology business...

China reports highly pathogenic H5N1 bird flu at chicken farm: OIE

Jun 27, 2018

BEIJING/PARIS (Reuters) – China reported an outbreak of highly pathogenic H5N1 bird flu at a farm in its northwest Qinghai province, the Paris-based World Organisation for Animal Health (OIE) said on Tuesday, citing a...

U.S. top court blocks California law on anti-abortion centers

Jun 26, 2018

By Andrew Chung WASHINGTON (Reuters) – The U.S. Supreme Court on Tuesday blocked a...

Modified polio vaccine extends lives in U.S. brain cancer study

Jun 26, 2018

By Julie Steenhuysen CHICAGO (Reuters) – Some 21 percent of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4 percent of patients with similar tumors...